Splenic ellipsoids: an early target for deposition of AA amyloid induced in mink

Tale N Wien1, Randi Sørby, Arild Espenes

  • 1Department of Rheumatology/Institute of Immunology, Rikshospitalet, University of Oslo, 0027 Oslo, Norway. t.n.wien@klinmed.uio.no

Insights

Researchers identified splenic ellipsoids as a novel target for AA amyloidosis in mink. This finding suggests these structures may play a key role in the initial formation of amyloid deposits.

Area of Science:

  • Veterinary Pathology
  • Immunology
  • Biochemistry

Background:

  • The spleen is a key organ for studying AA amyloidosis.
  • AA amyloidosis involves the deposition of amyloid fibrils, primarily in the spleen of affected animals.
  • Understanding early amyloid formation is crucial for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the precise location of splenic amyloid AA deposits in experimentally induced AA amyloidosis in mink.
  • To identify novel cellular or structural targets within the spleen for AA amyloid deposition.
  • To explore the potential role of specific proteins and molecules in the initial stages of splenic amyloid formation.

Main Methods:

  • Induction of AA amyloidosis in mink.
  • Histopathological examination of splenic tissues.
  • Immunohistochemical staining to detect amyloid AA, amyloid P component (AP), glycosaminoglycans (GAGs), apolipoprotein E (apoE), and apolipoprotein AI (apoAI).
  • Co-localization studies to determine the spatial relationship of detected molecules with AA deposits.

Main Results:

  • Splenic ellipsoids were identified as a novel target for AA amyloid deposits in mink.
  • Amyloid P component (AP), glycosaminoglycans (GAGs), and apolipoprotein E (apoE) were found to co-localize with AA deposits in the ellipsoids.
  • Apolipoprotein AI (apoAI) was also observed co-localizing with AA deposits within the splenic ellipsoids.
  • These findings indicate that splenic ellipsoids are sites of early amyloid fibrillogenesis and deposition.

Conclusions:

  • Splenic ellipsoids represent a significant, previously unrecognized site for AA amyloidosis initiation.
  • The co-localization of apoAI in ellipsoids suggests a potential mechanism involving the displacement of serum amyloid A (SAA) from high-density lipoprotein (HDL), facilitating amyloid formation.
  • These findings provide new insights into the pathogenesis of AA amyloidosis and highlight splenic ellipsoids as critical structures in disease development.